Discover the most recent news about our Company.
New Findings in DLBCL Research Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma.
Obesity, a complex and multifactorial disease, currently affects more than 13% of adults worldwide, according to the latest
We Drive Our International Expansion with the Support of ACCIÓ At Biosfer Teslab, we continue to expand our international presence
Nuclear magnetic resonance (NMR) is an advanced technology that allows the analysis of various biological matrices, from blood
The XXVI Jornadas of XULA (Xarxa d’Unitats de Lípids i Arteriosclerosi) are much more than just a scientific
Metabolomics has emerged in recent years as a powerful tool for the comprehensive assessment of biochemical changes occurring
This year, the Food and Agriculture Organization of the United Nations (FAO) has chosen the theme “The Right to Food
Data analysis has become a fundamental pillar for decision-making in healthcare. As the volume and complexity of clinical, genetic, epidemiological,
Today, on International Familial Hypercholesterolemia (FH) Day, we want to highlight this genetic condition that affects millions of people worldwide
Metabolomics is becoming a crucial tool in biomedical research. By analyzing the complete set of metabolites present in a biological
A recent study led by Dr. David Benaiges (1,2,3,4,5) from the Bariatric Surgery Unit at Hospital del Mar, in collaboration
The integration of metabolomics into clinical trials is revolutionizing medical research by providing detailed insights into the biochemical changes associated
